ECTRIMS 2023 | Pediatric onset MS: early signs and health system access

Helen Tremlett, PhD, The University of British Columbia, Vancouver, Canada, touches on the distinct opportunity that pediatric-onset multiple sclerosis (MS) provides in understanding the early signs of the disease. As a demographic that has lived a shorter span of life, children offer a relatively uncomplicated perspective, unaffected by various life events and exposures typical in adults. Dr Tremlett references a study that delves into the rate of hospital and physician visits prior to the onset of MS in pediatric populations across Canada and Sweden. A pressing query moving forward involves discerning the reasons these individuals access the healthcare system, potentially a decade or more before an MS diagnosis. Investigating potential variations across age, sex, and socioeconomic status remains crucial. This interview took place at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2023 in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.